Chetty R, Pulford K, Jones M, Mathieu-Mahul D, Close P, Hussein S, Pallesen G, Ralfkiaer E, Stein H, Gatter K
University Department of Cellular Science, University of Oxford, UK.
Hum Pathol. 1995 Sep;26(9):994-8. doi: 10.1016/0046-8177(95)90089-6.
A comparative study of the immunohistochemical (Stem cell leukemia/T-cell acute leukemia [SCL/TAL-1] protein expression) and genotypic (deletions in the SCL/tal-1 gene) findings in T-acute lymphoblastic leukemia (T-ALL) is presented. Formalin-fixed tissue from 50 cases of T-ALL were stained with a novel monoclonal antibody, 2TL 242, which recognizes SCL/TAL-1 protein. Twenty-four cases showed nuclear immunolabeling of leukemic cells. Nuclear positivity was not evident in any other type of leukemia or lymphoma tested with the antibody. Genotypic analysis of 25 cases of T-ALL showed a deletion involving the SCL/tal-1 gene in nine cases. These results suggest that protein expression is not dependent on derangement of the SCL/tal-1 gene, because immunohistochemical detection of the protein was noted in the presence and absence of a tal-d1 deletion.
本文呈现了一项关于T细胞急性淋巴细胞白血病(T-ALL)免疫组化(干细胞白血病/T细胞急性白血病[SCL/TAL-1]蛋白表达)和基因分型(SCL/tal-1基因缺失)结果的比较研究。用一种识别SCL/TAL-1蛋白的新型单克隆抗体2TL 242对50例T-ALL的福尔马林固定组织进行染色。24例白血病细胞显示核免疫标记。用该抗体检测的任何其他类型白血病或淋巴瘤中均未发现明显的核阳性。对25例T-ALL进行基因分型分析,结果显示9例存在涉及SCL/tal-1基因的缺失。这些结果表明,蛋白表达不依赖于SCL/tal-1基因的紊乱,因为在存在和不存在tal-d1缺失的情况下均检测到了该蛋白的免疫组化信号。